Get notified when TTRX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTurn Therapeutics files routine 8-K with undisclosed press release content
Filed May 18, 2026 · Period ending May 18, 2026 · ~1 min read
Key Changes
-
low
Company issued a press release on May 18, 2026, furnished under Regulation FD disclosure rules. The 8-K filing does not reveal the content or subject matter of the press release.
Item 7.01 verify on EDGAR → -
low
Press release attached as Exhibit 99.1 but content not summarized in the filing body, making it impossible to assess materiality or investor impact from the 8-K alone.
Exhibit 99.1 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade TTRX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify